Y.G. Montoyo-Pujol , A. Llopis-Gómez , D.A. Manresa-Crobalán , E. Castellón-Molla , J. Ponce , I. Lozano Cubo , H. Ballester , T.A. Martín-Bayón , S. Delgado-García , G. Peiro-Cabrera
{"title":"95P HHLA2、TMIGD2和KIR3DL3作为乳腺癌新的免疫检查点:体外和临床病理研究","authors":"Y.G. Montoyo-Pujol , A. Llopis-Gómez , D.A. Manresa-Crobalán , E. Castellón-Molla , J. Ponce , I. Lozano Cubo , H. Ballester , T.A. Martín-Bayón , S. Delgado-García , G. Peiro-Cabrera","doi":"10.1016/j.esmoop.2025.104649","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":11877,"journal":{"name":"ESMO Open","volume":"10 ","pages":"Article 104649"},"PeriodicalIF":7.1000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"95P HHLA2, TMIGD2, and KIR3DL3 as novel immune checkpoints in breast carcinoma: An in vitro and clinicopathological study\",\"authors\":\"Y.G. Montoyo-Pujol , A. Llopis-Gómez , D.A. Manresa-Crobalán , E. Castellón-Molla , J. Ponce , I. Lozano Cubo , H. Ballester , T.A. Martín-Bayón , S. Delgado-García , G. Peiro-Cabrera\",\"doi\":\"10.1016/j.esmoop.2025.104649\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":11877,\"journal\":{\"name\":\"ESMO Open\",\"volume\":\"10 \",\"pages\":\"Article 104649\"},\"PeriodicalIF\":7.1000,\"publicationDate\":\"2025-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ESMO Open\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2059702925005186\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ESMO Open","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2059702925005186","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
期刊介绍:
ESMO Open is the online-only, open access journal of the European Society for Medical Oncology (ESMO). It is a peer-reviewed publication dedicated to sharing high-quality medical research and educational materials from various fields of oncology. The journal specifically focuses on showcasing innovative clinical and translational cancer research.
ESMO Open aims to publish a wide range of research articles covering all aspects of oncology, including experimental studies, translational research, diagnostic advancements, and therapeutic approaches. The content of the journal includes original research articles, insightful reviews, thought-provoking editorials, and correspondence. Moreover, the journal warmly welcomes the submission of phase I trials and meta-analyses. It also showcases reviews from significant ESMO conferences and meetings, as well as publishes important position statements on behalf of ESMO.
Overall, ESMO Open offers a platform for scientists, clinicians, and researchers in the field of oncology to share their valuable insights and contribute to advancing the understanding and treatment of cancer. The journal serves as a source of up-to-date information and fosters collaboration within the oncology community.